About Us
Elem Bio focuses on the research and development of high-throughput gene editing tools, serving new drug development and basic research, and providing customers with high-throughput gene knockout, knock-in and knock-down products and services to accelerate the process of drug development and basic research.
The company is committed to creating the most simple and easy-to-use CRISPR gene knockout tool, freeing developers from tedious optimization experiments such as virus packaging, plasmid preparation, Cas9 protein concentration testing, and focusing on biological discovery.
Elem high-throughput gene knockout platform has completed 20000 gene knockout verification in human primary cells, more than 80% of the targets have more than 70% knockout efficiency, the company currently has gene knockout automation, high-throughput production platform, reaching 800 + high knockout efficiency KO cell capacity per month.
Automated, High-Throughput Gene Knockout
High Throughput Automated PCR
Development Process
News
The latest information, technical training activities and conference developments of Elem Biotech.
Elem Biology has established long-term cooperation with Bilibili Station Knowledge Sharing UP Master [CRISPR Senior Sister]. Welcome to scan the above two-dimensional code and join the [Qizi Plan]!
In August 2023, the "Qizi Plan" for sharing high-quality KO cells in scientific research jointly initiated by CRISPR and Elem Biology was officially released. China Typical Culture Collection Center (CCTCC), Hangzhou Hua 'an Biology and many other units joined the plan to jointly establish quality standards for the domestic gene editing cell industry, establish domestic high-end cell brands, save scientific research funds and build popular science undertakings for gene editing technology.
View All InformationTalent Recruitment
Looking forward to your joining, I hope we can join hands to create a better tomorrow!
Salary Range:
Number of Recruits:
Copyright © Elem Biotechnology (Wuhan) Co., Ltd.
LM